BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23084962)

  • 1. Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours.
    Rakha EA; Tan PH; Shaaban A; Tse GM; Esteller FC; van Deurzen CH; Purnell D; Stotter A; Chan T; Yamaguchi R; Dodwell D; Jager A; Soler MT; Juneinah E; Plaza ML; Hodi Z; McCulloch T; Lee AH; Ellis IO
    Breast; 2013 Feb; 22(1):13-8. PubMed ID: 23084962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
    Rakha EA; Tan PH; Varga Z; Tse GM; Shaaban AM; Climent F; van Deurzen CH; Purnell D; Dodwell D; Chan T; Ellis IO
    Br J Cancer; 2015 Jan; 112(2):283-9. PubMed ID: 25422911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in women aged 35 and under: prognosis and survival.
    Jmor S; Al-Sayer H; Heys SD; Payne S; Miller I; Ah-See A; Hutcheon A; Eremin O
    J R Coll Surg Edinb; 2002 Oct; 47(5):693-9. PubMed ID: 12463710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.
    Confavreux C; Lurkin A; Mitton N; Blondet R; Saba C; Ranchère D; Sunyach MP; Thiesse P; Biron P; Blay JY; Ray-Coquard I
    Eur J Cancer; 2006 Nov; 42(16):2715-21. PubMed ID: 17023158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
    Carter MR; Hornick JL; Lester S; Fletcher CD
    Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
    Barnes PJ; Boutilier R; Chiasson D; Rayson D
    Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic breast carcinoma: a cytohistologic and clinical study of 10 cases.
    Johnson TL; Kini SR
    Diagn Cytopathol; 1996 May; 14(3):226-32. PubMed ID: 8732652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer in very young women.
    Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J
    Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inoperable recurrence after breast-conserving surgical treatment and radiotherapy.
    Kurtz JM; Jacquemier J; Brandone H; Ayme Y; Hans D; Bressac C; Spitalier JM
    Surg Gynecol Obstet; 1991 May; 172(5):357-61. PubMed ID: 1851336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.